Skip to main content
. Author manuscript; available in PMC: 2018 Apr 1.
Published in final edited form as: Clin Gastroenterol Hepatol. 2016 Aug 25;15(4):584–593.e2. doi: 10.1016/j.cgh.2016.07.035

Table 1.

Recipient characteristics in A2ALL and SRTR

A2ALL (n=890)
N (%) or Mean (SD)
SRTR (n=45,423)
N (%) or Mean (SD)
Recipient age at transplant (years) 52.1 (11.1) 54.2 (10.1)
Female 367 (41%) 14903 (33%)
Hispanic/Latino 117 (13%) 5942 (13%)
Race
  White 779 (88%) 38644 (85%)
  Black 41 (5%) 4166 (9%)
  Asian 29 (3%) 2092 (5%)
  Other race 37 (4%) 521 (1%)
Recipient diagnosis (multiple possible)
  Acute liver failure 27 (3%) 3325 (7%)
  Alcohol-related cirrhosis 126 (14%) 11720 (26%)
  Autoimmune hepatitis 52 (6%) 1629 (4%)
  Cryptogenic cirrhosis 78 (9%) 3593 (8%)
  HBV 22 (2%) 1618 (4%)
  HCV 330 (37%) 19427 (43%)
  Metabolic liver disease 35 (4%) 1642 (4%)
  PBC 79 (9%) 1717 (4%)
  PSC 161 (18%) 2445 (5%)
  Other diagnosis 69 (8%) 10774 (24%)
MELD at transplant 16.7 (6.8)δ 20.9 (9.7)
Recipient on ventilator at transplant 16 (2%) 2187 (5%)
Recipient on dialysis at transplant 12 (1%)¥ 3160 (7%)
Donor age at transplant (years) 37.9 (12.9)¥ 41.9 (16.8)
Transplant type
  Biologically related LDLT 397 (45%) 1172 (3%)
  Non-biologically related LDLT 235 (26%) 629 (1%)
  DDLT 258 (29%) 43622 (96%)
Cold ischemia time (min) (LDLT/DDLT) 66.4 (77.6)/430.3 (187.1)δ 142.8 (280.4)/414.8 (194.4)δ

Missing <1%

¥

Missing <3%

δ

Missing <10%.

All other variables had no missing data.